Cargando…
The PreCardio-study protocol – a randomized clinical trial of a multidisciplinary electronic cardiovascular prevention programme
BACKGROUND: Cardiovascular diseases (CVD) are the leading cause of death and the third cause of disability in Europe. Prevention programmes should include interventions aimed at a reduction of medical risk factors (hypertension, hypercholesterol, hyperglycemia, overweight and obesity) as well as beh...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2045658/ https://www.ncbi.nlm.nih.gov/pubmed/17784946 http://dx.doi.org/10.1186/1471-2261-7-27 |
_version_ | 1782137141106573312 |
---|---|
author | Claes, Neree Jacobs, Nele |
author_facet | Claes, Neree Jacobs, Nele |
author_sort | Claes, Neree |
collection | PubMed |
description | BACKGROUND: Cardiovascular diseases (CVD) are the leading cause of death and the third cause of disability in Europe. Prevention programmes should include interventions aimed at a reduction of medical risk factors (hypertension, hypercholesterol, hyperglycemia, overweight and obesity) as well as behavioural risk factors (sedentary lifestyle, high fat intake and low fruit and vegetable intake, smoking). The aim of this study is to investigate the effects of a multifaceted, multidisciplinary electronic prevention programme on cardiovascular risk factors. METHODS/DESIGN: In a randomized controlled trial, one group will receive a maximal intervention (= intervention group). The intervention group will be compared to the control group receiving a minimal intervention. An inclusion of 350 patients in total, with a follow-up of 3 years is foreseen. The inclusion criteria are age between 25–65 and insured by the Onderlinge Ziekenkas, insuring for guaranteed income in case of illness for self-employed. The maximal intervention group receives several prevention consultations by their general practitioner (GP) using a new type of cardiovascular risk calculator with personalised feedback on behavioural risk factors. These patients receive a follow-up with intensive support of health behaviour change via different methods, i.e. a tailored website and personal advice of a multidisciplinary team (psychologist, physiotherapist and dietician). The aim of this strategy is to reduce cardiovascular risk factors according to the guidelines. The primary outcome measures will be cardiovascular risk factors. The secondary outcome measures are cardiovascular events, quality of life, costs and incremental cost effectiveness ratios. The control group receives prevention consultations using a new type of cardiovascular risk calculator and general feedback. DISCUSSION: This trial incorporates interventions by GPs and other health professionals aiming at a reduction of medical and behavioural cardiovascular risk factors. An assessment of clinical, psychological and economical outcome measures will be performed. TRIAL REGISTRATION: ISRCTN23940498 |
format | Text |
id | pubmed-2045658 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-20456582007-10-31 The PreCardio-study protocol – a randomized clinical trial of a multidisciplinary electronic cardiovascular prevention programme Claes, Neree Jacobs, Nele BMC Cardiovasc Disord Study Protocol BACKGROUND: Cardiovascular diseases (CVD) are the leading cause of death and the third cause of disability in Europe. Prevention programmes should include interventions aimed at a reduction of medical risk factors (hypertension, hypercholesterol, hyperglycemia, overweight and obesity) as well as behavioural risk factors (sedentary lifestyle, high fat intake and low fruit and vegetable intake, smoking). The aim of this study is to investigate the effects of a multifaceted, multidisciplinary electronic prevention programme on cardiovascular risk factors. METHODS/DESIGN: In a randomized controlled trial, one group will receive a maximal intervention (= intervention group). The intervention group will be compared to the control group receiving a minimal intervention. An inclusion of 350 patients in total, with a follow-up of 3 years is foreseen. The inclusion criteria are age between 25–65 and insured by the Onderlinge Ziekenkas, insuring for guaranteed income in case of illness for self-employed. The maximal intervention group receives several prevention consultations by their general practitioner (GP) using a new type of cardiovascular risk calculator with personalised feedback on behavioural risk factors. These patients receive a follow-up with intensive support of health behaviour change via different methods, i.e. a tailored website and personal advice of a multidisciplinary team (psychologist, physiotherapist and dietician). The aim of this strategy is to reduce cardiovascular risk factors according to the guidelines. The primary outcome measures will be cardiovascular risk factors. The secondary outcome measures are cardiovascular events, quality of life, costs and incremental cost effectiveness ratios. The control group receives prevention consultations using a new type of cardiovascular risk calculator and general feedback. DISCUSSION: This trial incorporates interventions by GPs and other health professionals aiming at a reduction of medical and behavioural cardiovascular risk factors. An assessment of clinical, psychological and economical outcome measures will be performed. TRIAL REGISTRATION: ISRCTN23940498 BioMed Central 2007-09-04 /pmc/articles/PMC2045658/ /pubmed/17784946 http://dx.doi.org/10.1186/1471-2261-7-27 Text en Copyright © 2007 Neree and Jacobs; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Study Protocol Claes, Neree Jacobs, Nele The PreCardio-study protocol – a randomized clinical trial of a multidisciplinary electronic cardiovascular prevention programme |
title | The PreCardio-study protocol – a randomized clinical trial of a multidisciplinary electronic cardiovascular prevention programme |
title_full | The PreCardio-study protocol – a randomized clinical trial of a multidisciplinary electronic cardiovascular prevention programme |
title_fullStr | The PreCardio-study protocol – a randomized clinical trial of a multidisciplinary electronic cardiovascular prevention programme |
title_full_unstemmed | The PreCardio-study protocol – a randomized clinical trial of a multidisciplinary electronic cardiovascular prevention programme |
title_short | The PreCardio-study protocol – a randomized clinical trial of a multidisciplinary electronic cardiovascular prevention programme |
title_sort | precardio-study protocol – a randomized clinical trial of a multidisciplinary electronic cardiovascular prevention programme |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2045658/ https://www.ncbi.nlm.nih.gov/pubmed/17784946 http://dx.doi.org/10.1186/1471-2261-7-27 |
work_keys_str_mv | AT claesneree theprecardiostudyprotocolarandomizedclinicaltrialofamultidisciplinaryelectroniccardiovascularpreventionprogramme AT jacobsnele theprecardiostudyprotocolarandomizedclinicaltrialofamultidisciplinaryelectroniccardiovascularpreventionprogramme AT claesneree precardiostudyprotocolarandomizedclinicaltrialofamultidisciplinaryelectroniccardiovascularpreventionprogramme AT jacobsnele precardiostudyprotocolarandomizedclinicaltrialofamultidisciplinaryelectroniccardiovascularpreventionprogramme |